In subacute cutaneous lupus eryhematosus (SCLE) the cutaneous antigens constitute the main source of Ro and La autoantigens. The aim of this investigation was to demonstrate if UV light increases the availability of Ro autoantigen in the skin, also the blocking effect of Ac-DEVD-CMK a caspase inhibitor was assessed. For this purpose newborn Balb/c mice were UVB irradiated (5-30 mJ/cm 2 ) equivalent to a moderate to severe sunburn. Animals were injected with monoclonal anti-Ro antibodies from SCLE patients. Apoptosis was also induced by anti-Fas antibody injection. Skin samples were examined by direct immunofluoresence, by TUNEL, and the expression of caspase 3 by RT-PCR. Major findings of present studies were: 1. UVB irradiation and anti-Fas induced apoptosis of keratinocytes. 2. Apoptosis redistribute the Ro antigen on cell surface and is better triggered by Ro antibody. 3. The caspase 3 inhibitor Ac-DEVD-CMK decreases the availability of Ro autoantigen in epidermis and prevents deposition of anti-Ro. In conclusion, the caspase pathway would be blocked to avoid anti-Ro deposition along skin; this finding would be a prospect in the treatment of SCLE patients.
Introduction
Casciola-Rosen et al. demonstrated that autoantigens in lupus lacked of restriction to any subcellular location and demonstrated that under apoptosis, dying cells exhibited intracellular autoantigens on the cell surface throughout a physiologic process (Casciola-Rosen et al. 1994) . In photosensitive subsets of lupus erythematosus has been recognized that apoptotic epidermal cells constitute a possible source of autoantigens; whereas in systemic lupus eythematosus (SLE) the apoptotic endothelial cells and lymphocytes probably contribute to trigger terminal-organ damage. Apoptosis guarantees the cellular exchange; therefore a healthy individual produce 1 £ 20 9 Kg of cellular debris which is cleaned by phagocytes; an inappropriate cleaning of apoptotic material would triggers autoantibody production in individuals genetically predisposed (Lorenz et al. 2000) . The epidermal release of intracellular antigens would induce in situ the formation of immune complexes that are related with the relapses of skin lesions, in consequence, the study of the factors that activate apoptosis are of clinical interest because would allow to propose therapeutic strategies to obtain clinical recovery. The aim of present study was to induce a redistribution of the Ro antigen of the skin in newborn Balb/c mice under UV irradiation, such redistribution was monitored by anti-Ro antibodies injected intraperitoneally. Additionally, we assess in the skin the effect of the caspase inhibitor Ac-DEVD-CMK on Ro/anti-Ro immune complex formation.
Material and methods
Balb/c mice groups and then injected with anti-Ro. Animals were injected intra-peritoneal using a syringe in volumes adjusted to 50 ml. The antibodies were administrated in a dosage of 5 mg/g of body weight. The caspase inhibitor Ac-DEVD-CMK dissolved in DMSO adjusted to 20 mM was adjusted in PBS a final volume of 50 ml. A monoclonal anti-Ro antibody obtained from CLB (The Netherlands), or a polyclonal anti-Ro autoantibody from a SCLE patient, were used in all assays. The monoclonal anti-Fas antibody was obtained from Santa Cruz Biotechnology.
UV irradiation
Was carried out by means of a UV lamp (Black-Ray UVL). The total dose of UV was 5 -30 mJ/cm 2 , which is equivalent in humans to a moderate to severe sunburn.
Skin biopsies
Samples were obtained by means of a 2.5 mm punch, and were used for immunohistology and for RNA and DNA extraction by TRIsol, the epidermis was obtained by splitting with 10% dispase (Sigma). Direct immunofluorescence was done in a 4-mm slice of skin, and immune deposition was detected by FITC-rabbit anti human polyclonal IgG, or FITC-rabbit antiMouse (Sigma) in animals injected with monoclonal anti-Ro. TdT-mediated dUTP nick end labelling (TUNEL): Nuclear stripping was performed with 10 mM Tris -HCl, pH 8.0 followed by 15 min in 20 mg/ml proteinase K. Elongation of DNA fragments was done by incubation with reaction mixture (DDW, 10XTdT buffer (30 mM Tris base, 140 mM sodium cacodylate, pH 7.2, 1 mM cobalt chloride, 1 mM DTT; 10% of the final volume), fluorescein-11-dUTP (0.5 mg dissolved in 1 ml of 10 mM Tris -HCl, pH 7.0), and TdT enzyme (0.3 enzyme units/ml). Reaction was terminated by adding 300 mM NaCl, 30 mM sodium citrate, and pH 8.0. Finally the slides were evaluated under fluorescent microscopy to differentiate the true green tag of apoptotic cells from background incorporation, cells were counterstained with 0.5% propidium iodide, giving the nonapoptotic nuclei develop a red stain. Oligonucleotides: Caspase 3 forward 5 0 -TCC AGT CGG AGG CCA GAT CTG AG-3 0 , backward 5 0 -CTG AAG CCT GCC TCC CGG GAT GA-3 0 [SNP000005036] and G3PDH forward 5 0 -TGA AGG TCG GTG TGA ACG GAT TTG GC-3 0 , backward 5 0 -CAT GTA GGC CAT GAG GTC CAC CAC-3 0 (Clontech).
Reverse-transcription/polymerase chain reaction (RT-PCR)
RNA (250 ng) was mixed with 200 mM dNTP and 0.7 mM of the backward primer and 5 U/20 ml of rTth/DNA polymerase and incubated at 708C for 10 min. Amplification of caspase 3 and G3PDH cDNAs was carried out by PCR by addition of 0.15 mM of the forward primer; using 30 cycles of 948C for 2 min, 488C for 2 min and 728C for 1.4 min. PCR products were electrophoresed in 0.8% agarose containing 0.5 mg/ml of ethidium bromide, and were observed under UV light. Caspase 3 was also detected by immunoperoxidase staining using an anti-caspase 3 antibody (Santa Cruz Biotechnology).
Results
Non-irradiated animals did not show epidermal apoptosis; meanwhile UVB irradiated and anti-Fas injected animals exhibited apoptotic features induced in keratinocytes; such phenomenon was larger in UVB irradiated animals. The expression of caspase 3 by RT-PCR and immunohistochemistry of skin was evident in animals UVB irradiated or treated with anti-Fas antibody. On the other hand, the inhibitory effect of Ac-DEVD-CMK on apoptosis was remarkable, since apoptotic features were completely abolished in animals under treatment with this caspase 3 inhibitor. Under apoptosis Ro antigen became detectable in epidermis, therefore apoptosis redistribute the Ro antigen on cytoplasm and cell surface; therefore apoptotic keratinocytes were better triggered by the monoclonal or polyclonal anti-Ro antibodies. As expected the caspase 3 inhibitor Ac-DEVD-CMK decreased the availability of Ro autoantigen in epidermis, such decrease resulted in abolishment of anti-Ro deposition in epidermis, therefore skin biopsies of animals treated with this caspase 3 inhibitor resulted negative. Controls injected with normal human IgG were negative (Figure 1 ).
Discussion
Main results of present study demonstrate that UVB irradiation and anti-Fas induces apoptosis of keratinocytes and Ro antigen translocation to cell surface, this facilitate the anti-Ro antibody triggering. We also show that Ac-DEVD-CMK decreases the availability Ro autoantigen and the anti-Ro deposition on the skin. In lupus sun exposure induces apoptosis and would contribute to the pathogenesis of skin lesions in patients with cutaneous lupus phenotype (Kelly et al. 2006; Kuhn et al. 2006) . The release of intact or modified intracellular ribonucleoproteins including Ro60 (Ramirez-Sandoval et al. 2003 ) promotes the dendritic cell maturation and the production of interferon, that is critical in autoantibody production and lupus relapses (Dall'era et al. 2005; Meller et al. 2005) . Additionally, apoptosis induces secondary necrosis and chemokine production that is followed by recruitment and activation of autoimmune T cells and IFN-alpha-producing plasmacytoid dendritic cells creating a vicious circle. The local anti-Ro antibody production and effectors cytokines and leukocyte recruitment leads the development of cutaneous lupus lesions. The importance of present observation is that a caspase 3 inhibitor is capable to block the release of intracellular ribonucleoproteins such as Ro that is involved in SCLE pathogenesis; this experimental therapy has been successfully used to ameliorate kidney disease in a transgenic mouse model of lupus nephritis (Seery et al. 2001 ).
